The management of migraine.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000700:Analgesics / Q000627:therapeutic use; D000932:Antiemetics / Q000627:therapeutic use; D002648:Child; D004359:Drug Therapy, Combination; D004878:Ergotamine / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D008784:Methysergide / Q000627:therapeutic use; D008881:Migraine Disorders / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D009119:Muscle Contraction; D010672:Phenytoin / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000700:Analgesics; D000932:Antiemetics; D008996:Monoamine Oxidase Inhibitors; D014149:Tranquilizing Agents; D010672:Phenytoin; D004878:Ergotamine; D008784:Methysergide